With the advent of multidisciplinary therapy over the past two decades, there have been major advances in the management of children with pelvic rhabdomyosarcoma (RMS). Overall 3 year survival rates of 70-78% have been reported (Maurer et al., 1988; Raney et al., 1990) . The challenge now is to find a suitable combination of treatment modalities that will maintain this high cure rate with a minimum of morbidity -'cure at least cost'. Preservation of pelvic organs, especially the urinary bladder and the vagina, has become one of the main goals of modern treatment (Ortega et al., 1979; Voute et al., 1981; Massad et al., 1991) .
The survival of 20 childrn with pelvic RMS treated between 1976 and 1983 in our hospital with chemotherapy, radiotherapy and radical surgery was 55%, and only 6 of the 11 survivors retained their bladders (Broecker et al., 1988) . Despite these disappointing results we decided, in 1983, to adopt a more conservative surgical policy. After initial intensive chemotherapy, local removal of tumour was undertaken with a view to preserving the bladder. Patients with completely resected tumours received only chemotherapy postoperatively, whereas those with residual disease were treated by combined chemotherapy and radiotherapy (Atra et al., 1994) . The purpose of this study was to evaluate the longterm function of the retained bladders in surviving patients and to assess whether this treatment approach had any adverse effects on the upper urinary tract.
Patie.s and mthod Between 1983 and 1988, 26 disappointing 3 year disease-free survival (DFS) rate of 52%, significantly inferior (P = 0.02) to the 70% DFS achieved in the IRS-I study in which radical primary surgery was used.
Another disappointment was that in IRS-II only 22% of patients with bladder/prostate primary tumours retained their bladders at 3 years, an outcome similar to that of IRS-I (23% with preserved bladders) (Maurer et al., 1988; . Similar figures had also been reported by Grosfeld (1983) and McLorie (1989) , who concluded that bladder salvage, although desirable, is possible only in the complete absnce of residual disease after chemoradiotherapy (Grosfeld et al., 1983; McLorie et al., 1989) .
More encouraging results have been reported from other centres. Ghavimi et al. (1984) for instance, reported a 50% bladder salvage rate among 18 survivors, and Pratt et al. (1984) have reported a 73% survival and 81% bladder salvage rate. However, very few reports even mention the functional status of the bladders or the upper urinary tracts (Ortega, 1979; Voute et al., 1981; Hays et al., 1982 Hays et al., , 1990 Grosfeld et al., 1983; Ghavimi et al., 1984; Pratt, 1984; Maurer et al., 1988; McLorie et al., 1989; Crist et al., 1990; Raney et al., 1990; La Quaglia, 1991; Massad et al., 1991) and to our knowledge no detailed studies, such as this one, have been published.
Although the numbers in our study are small, the overall 3 year survival rate of 73% and bladder salvage rate, in our survivors, of 89% compare favourably with other reported series (Ortega, 1979; Voute et al., 1981; Grosfeld et al., 1983; Koff, 1983; Ghavimi et al., 1984; Pratt, 1984; Maurer et al., 1988; McClorie et al., 1989; Crist et al., 1990; La Quaglia et al., 1990; Raney et al., 1990; La Quaglia, 1991; Massad et al., 1991) . The high bladder salvage rate is the consequence of (a) our policy of treating local residual disease with irradiation rather than radical surgery, unless there was unequivocal persistent tumour-, (b) during serial endoscopic follow-up, cautious interpretation of 'positive' histopathological reports on biopsies taken from the site of previous tumour-bearing areas that appear macroscopically normal (Atra et al., 1994) ; and (c) cautious interpretation of follow-up pelvic computerised tomographic (Cr) scans (Atra et al., 1994) . The surgical expertise available in our institute for successful excision of residual tumours in the bladder base, using the submucosal resection technique without resorting to total cystourethrectomy, and for any subsequent urinary tract reconstruction is also a crucial part of this bladder conservation policy.
Early local irradiation has been advocated by Tefft et al. (1980) for patients with residual disease and involvement of regional nodes. We do not dissect the internal iliac nodes in our patients and we have achieved good 'local tumour control' despite delayed irradiation for patients with smallvolume residual post-surgical disease. The morbidity of bladder dysfunction and the rate of deterioration of the upper urinary tracts are, however, important considerations in a conservative surgical policy which also involves radiotherapy.
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